Novel Therapeutics in Psoriatic Arthritis. What Is in the Pipeline? View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2018-07

AUTHORS

Ofir Elalouf, Vinod Chandran

ABSTRACT

PURPOSE OF REVIEW: To highlight the recently approved therapeutic agents in psoriatic arthritis (PsA), drugs in the pipeline, as well as to discuss efficacy with regard to different clinical domains of PsA. RECENT FINDINGS: More than 15 years ago, tumor necrosis factor inhibitors (TNFi) were the first biologic disease modifying anti-rheumatic drugs (bDMARDs) that were approved for the treatment of PsA. Since then, multiple new therapeutic agents inhibiting other targets have emerged including biologics targeting interleukin (IL) 12/23, and IL 17 and oral agents targeting phosphodiesterase 4 (PDE4) and Janus kinases (JAKs). Many new agents with various modes of action including selective inhibition of IL 23, therapies promoting activated T cell apoptosis, inhibition of tyrosine kinase 2 (TYK2), and more are under active assessment in ongoing clinical trials. Effective therapies for treating PsA have emerged over the last 15 years and newer agents continue to be discovered, allowing greater therapeutic options for controlling psoriatic disease activity and preventing joint damage and disability. Personalized therapy for patients with PsA is now a possibility. More... »

PAGES

36

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11926-018-0746-0

DOI

http://dx.doi.org/10.1007/s11926-018-0746-0

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1104297923

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/29846825


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of Toronto", 
          "id": "https://www.grid.ac/institutes/grid.17063.33", 
          "name": [
            "Department of Medicine, Division of Rheumatology, University of Toronto, Toronto, Canada", 
            "Centre for Prognosis Studies in the Rheumatic Diseases, Krembil Research Institute, Toronto Western Hospital, University Health Network Toronto, 1E 416, 399 Bathurst Street, M5T 2S8, Toronto, ON, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Elalouf", 
        "givenName": "Ofir", 
        "id": "sg:person.01206032647.47", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01206032647.47"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Toronto", 
          "id": "https://www.grid.ac/institutes/grid.17063.33", 
          "name": [
            "Centre for Prognosis Studies in the Rheumatic Diseases, Krembil Research Institute, Toronto Western Hospital, University Health Network Toronto, 1E 416, 399 Bathurst Street, M5T 2S8, Toronto, ON, Canada", 
            "Department of Medicine, Division of Rheumatology, University of Toronto, Toronto, ON, Canada", 
            "Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada", 
            "Institute of Medical Science, University of Toronto, Toronto, ON, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chandran", 
        "givenName": "Vinod", 
        "id": "sg:person.01234257431.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01234257431.51"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1136/annrheumdis-2015-207963", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002021761"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1112072", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002267298"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/annrheumdis-2013-204902", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002806444"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/annrheumdis-2013-205056", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004467907"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.39573", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005700908"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s13075-016-0981-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005855813", 
          "https://doi.org/10.1186/s13075-016-0981-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(13)60594-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006274708"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.39700", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016310829"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/bjd.15152", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018287212"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/ar2670", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020428573", 
          "https://doi.org/10.1186/ar2670"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/annrheumdis-2015-208337", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022767391"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(13)61134-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022790286"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/14712598.2016.1198765", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029187928"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(16)32537-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029712001"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/annrheumdis-2013-203696", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029726499"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1315231", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030324726"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1412679", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035341201"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/annrheumdis-2012-203091", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038077135"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(15)61134-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040399320"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/annrheumdis-2013-204655", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041188784"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.37876", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042418966"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/annrheumdis-2016-209709", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044839867"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1314258", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049860938"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/annrheumdis-2016-210105", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062759478"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1517/14712598.2015.1103733", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1067589152"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3899/jrheum.151376", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071544067"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmra1505557", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1084149679"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(17)30570-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1084812160"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1607017", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1084964859"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/annrheumdis-2016-210724", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1085328641"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(17)31429-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1085579124"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmc1704342", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1085618733"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(17)31279-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1085886984"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/bjd.15857", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1090920617"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.40226", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1091204192"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1615977", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1092274246"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1615975", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1092274251"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/annrheumdis-2017-eular.1164", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1095977238"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/annrheumdis-2017-eular.1164", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1095977238"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/annrheumdis-2017-212127", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1099928962"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2018-07", 
    "datePublishedReg": "2018-07-01", 
    "description": "PURPOSE OF REVIEW: To highlight the recently approved therapeutic agents in psoriatic arthritis (PsA), drugs in the pipeline, as well as to discuss efficacy with regard to different clinical domains of PsA.\nRECENT FINDINGS: More than 15\u00a0years ago, tumor necrosis factor inhibitors (TNFi) were the first biologic disease modifying anti-rheumatic drugs (bDMARDs) that were approved for the treatment of PsA. Since then, multiple new therapeutic agents inhibiting other targets have emerged including biologics targeting interleukin (IL) 12/23, and IL 17 and oral agents targeting phosphodiesterase 4 (PDE4) and Janus kinases (JAKs). Many new agents with various modes of action including selective inhibition of IL 23, therapies promoting activated T cell apoptosis, inhibition of tyrosine kinase 2 (TYK2), and more are under active assessment in ongoing clinical trials. Effective therapies for treating PsA have emerged over the last 15\u00a0years and newer agents continue to be discovered, allowing greater therapeutic options for controlling psoriatic disease activity and preventing joint damage and disability. Personalized therapy for patients with PsA is now a possibility.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s11926-018-0746-0", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1021176", 
        "issn": [
          "1523-3774", 
          "1534-6307"
        ], 
        "name": "Current Rheumatology Reports", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "7", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "20"
      }
    ], 
    "name": "Novel Therapeutics in Psoriatic Arthritis. What Is in the Pipeline?", 
    "pagination": "36", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "58a211361141eb4abc6806905ce0c6e31a8bc2b61669ec4cc6b3995b1d55db0a"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "29846825"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "100888970"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11926-018-0746-0"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1104297923"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11926-018-0746-0", 
      "https://app.dimensions.ai/details/publication/pub.1104297923"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T21:46", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8687_00000564.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1007%2Fs11926-018-0746-0"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11926-018-0746-0'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11926-018-0746-0'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11926-018-0746-0'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11926-018-0746-0'


 

This table displays all metadata directly associated to this object as RDF triples.

199 TRIPLES      21 PREDICATES      68 URIs      21 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11926-018-0746-0 schema:about anzsrc-for:11
2 anzsrc-for:1103
3 schema:author Na43dcf3c09d24b079101646d94e47a3f
4 schema:citation sg:pub.10.1186/ar2670
5 sg:pub.10.1186/s13075-016-0981-6
6 https://doi.org/10.1002/art.37876
7 https://doi.org/10.1002/art.39573
8 https://doi.org/10.1002/art.39700
9 https://doi.org/10.1002/art.40226
10 https://doi.org/10.1016/s0140-6736(13)60594-2
11 https://doi.org/10.1016/s0140-6736(13)61134-4
12 https://doi.org/10.1016/s0140-6736(15)61134-5
13 https://doi.org/10.1016/s0140-6736(16)32537-5
14 https://doi.org/10.1016/s0140-6736(17)30570-6
15 https://doi.org/10.1016/s0140-6736(17)31279-5
16 https://doi.org/10.1016/s0140-6736(17)31429-0
17 https://doi.org/10.1056/nejmc1704342
18 https://doi.org/10.1056/nejmoa1112072
19 https://doi.org/10.1056/nejmoa1314258
20 https://doi.org/10.1056/nejmoa1315231
21 https://doi.org/10.1056/nejmoa1412679
22 https://doi.org/10.1056/nejmoa1607017
23 https://doi.org/10.1056/nejmoa1615975
24 https://doi.org/10.1056/nejmoa1615977
25 https://doi.org/10.1056/nejmra1505557
26 https://doi.org/10.1080/14712598.2016.1198765
27 https://doi.org/10.1111/bjd.15152
28 https://doi.org/10.1111/bjd.15857
29 https://doi.org/10.1136/annrheumdis-2012-203091
30 https://doi.org/10.1136/annrheumdis-2013-203696
31 https://doi.org/10.1136/annrheumdis-2013-204655
32 https://doi.org/10.1136/annrheumdis-2013-204902
33 https://doi.org/10.1136/annrheumdis-2013-205056
34 https://doi.org/10.1136/annrheumdis-2015-207963
35 https://doi.org/10.1136/annrheumdis-2015-208337
36 https://doi.org/10.1136/annrheumdis-2016-209709
37 https://doi.org/10.1136/annrheumdis-2016-210105
38 https://doi.org/10.1136/annrheumdis-2016-210724
39 https://doi.org/10.1136/annrheumdis-2017-212127
40 https://doi.org/10.1136/annrheumdis-2017-eular.1164
41 https://doi.org/10.1517/14712598.2015.1103733
42 https://doi.org/10.3899/jrheum.151376
43 schema:datePublished 2018-07
44 schema:datePublishedReg 2018-07-01
45 schema:description PURPOSE OF REVIEW: To highlight the recently approved therapeutic agents in psoriatic arthritis (PsA), drugs in the pipeline, as well as to discuss efficacy with regard to different clinical domains of PsA. RECENT FINDINGS: More than 15 years ago, tumor necrosis factor inhibitors (TNFi) were the first biologic disease modifying anti-rheumatic drugs (bDMARDs) that were approved for the treatment of PsA. Since then, multiple new therapeutic agents inhibiting other targets have emerged including biologics targeting interleukin (IL) 12/23, and IL 17 and oral agents targeting phosphodiesterase 4 (PDE4) and Janus kinases (JAKs). Many new agents with various modes of action including selective inhibition of IL 23, therapies promoting activated T cell apoptosis, inhibition of tyrosine kinase 2 (TYK2), and more are under active assessment in ongoing clinical trials. Effective therapies for treating PsA have emerged over the last 15 years and newer agents continue to be discovered, allowing greater therapeutic options for controlling psoriatic disease activity and preventing joint damage and disability. Personalized therapy for patients with PsA is now a possibility.
46 schema:genre research_article
47 schema:inLanguage en
48 schema:isAccessibleForFree false
49 schema:isPartOf Na2b707675ec14d6ea3916a627abae764
50 Nbbf73c3dbcb24dc58236626b4c41745b
51 sg:journal.1021176
52 schema:name Novel Therapeutics in Psoriatic Arthritis. What Is in the Pipeline?
53 schema:pagination 36
54 schema:productId N08473435692d48af9694d44423904758
55 N2afd2dfe3f6a44a99af3398b75c38b15
56 N2bb54dbc4f7f4591970e157a0c072130
57 N3d42113510f74e91b374844a3f005e53
58 Nc696343f84574d8cb3b442e4a3c3d9be
59 schema:sameAs https://app.dimensions.ai/details/publication/pub.1104297923
60 https://doi.org/10.1007/s11926-018-0746-0
61 schema:sdDatePublished 2019-04-10T21:46
62 schema:sdLicense https://scigraph.springernature.com/explorer/license/
63 schema:sdPublisher N78a496c1b41a46f9b43ffaf25a28ddcc
64 schema:url https://link.springer.com/10.1007%2Fs11926-018-0746-0
65 sgo:license sg:explorer/license/
66 sgo:sdDataset articles
67 rdf:type schema:ScholarlyArticle
68 N08473435692d48af9694d44423904758 schema:name doi
69 schema:value 10.1007/s11926-018-0746-0
70 rdf:type schema:PropertyValue
71 N1a253b294cac49109a3d622bf8f7d393 rdf:first sg:person.01234257431.51
72 rdf:rest rdf:nil
73 N2afd2dfe3f6a44a99af3398b75c38b15 schema:name nlm_unique_id
74 schema:value 100888970
75 rdf:type schema:PropertyValue
76 N2bb54dbc4f7f4591970e157a0c072130 schema:name readcube_id
77 schema:value 58a211361141eb4abc6806905ce0c6e31a8bc2b61669ec4cc6b3995b1d55db0a
78 rdf:type schema:PropertyValue
79 N3d42113510f74e91b374844a3f005e53 schema:name dimensions_id
80 schema:value pub.1104297923
81 rdf:type schema:PropertyValue
82 N78a496c1b41a46f9b43ffaf25a28ddcc schema:name Springer Nature - SN SciGraph project
83 rdf:type schema:Organization
84 Na2b707675ec14d6ea3916a627abae764 schema:issueNumber 7
85 rdf:type schema:PublicationIssue
86 Na43dcf3c09d24b079101646d94e47a3f rdf:first sg:person.01206032647.47
87 rdf:rest N1a253b294cac49109a3d622bf8f7d393
88 Nbbf73c3dbcb24dc58236626b4c41745b schema:volumeNumber 20
89 rdf:type schema:PublicationVolume
90 Nc696343f84574d8cb3b442e4a3c3d9be schema:name pubmed_id
91 schema:value 29846825
92 rdf:type schema:PropertyValue
93 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
94 schema:name Medical and Health Sciences
95 rdf:type schema:DefinedTerm
96 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
97 schema:name Clinical Sciences
98 rdf:type schema:DefinedTerm
99 sg:journal.1021176 schema:issn 1523-3774
100 1534-6307
101 schema:name Current Rheumatology Reports
102 rdf:type schema:Periodical
103 sg:person.01206032647.47 schema:affiliation https://www.grid.ac/institutes/grid.17063.33
104 schema:familyName Elalouf
105 schema:givenName Ofir
106 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01206032647.47
107 rdf:type schema:Person
108 sg:person.01234257431.51 schema:affiliation https://www.grid.ac/institutes/grid.17063.33
109 schema:familyName Chandran
110 schema:givenName Vinod
111 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01234257431.51
112 rdf:type schema:Person
113 sg:pub.10.1186/ar2670 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020428573
114 https://doi.org/10.1186/ar2670
115 rdf:type schema:CreativeWork
116 sg:pub.10.1186/s13075-016-0981-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005855813
117 https://doi.org/10.1186/s13075-016-0981-6
118 rdf:type schema:CreativeWork
119 https://doi.org/10.1002/art.37876 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042418966
120 rdf:type schema:CreativeWork
121 https://doi.org/10.1002/art.39573 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005700908
122 rdf:type schema:CreativeWork
123 https://doi.org/10.1002/art.39700 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016310829
124 rdf:type schema:CreativeWork
125 https://doi.org/10.1002/art.40226 schema:sameAs https://app.dimensions.ai/details/publication/pub.1091204192
126 rdf:type schema:CreativeWork
127 https://doi.org/10.1016/s0140-6736(13)60594-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006274708
128 rdf:type schema:CreativeWork
129 https://doi.org/10.1016/s0140-6736(13)61134-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022790286
130 rdf:type schema:CreativeWork
131 https://doi.org/10.1016/s0140-6736(15)61134-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040399320
132 rdf:type schema:CreativeWork
133 https://doi.org/10.1016/s0140-6736(16)32537-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029712001
134 rdf:type schema:CreativeWork
135 https://doi.org/10.1016/s0140-6736(17)30570-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084812160
136 rdf:type schema:CreativeWork
137 https://doi.org/10.1016/s0140-6736(17)31279-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1085886984
138 rdf:type schema:CreativeWork
139 https://doi.org/10.1016/s0140-6736(17)31429-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1085579124
140 rdf:type schema:CreativeWork
141 https://doi.org/10.1056/nejmc1704342 schema:sameAs https://app.dimensions.ai/details/publication/pub.1085618733
142 rdf:type schema:CreativeWork
143 https://doi.org/10.1056/nejmoa1112072 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002267298
144 rdf:type schema:CreativeWork
145 https://doi.org/10.1056/nejmoa1314258 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049860938
146 rdf:type schema:CreativeWork
147 https://doi.org/10.1056/nejmoa1315231 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030324726
148 rdf:type schema:CreativeWork
149 https://doi.org/10.1056/nejmoa1412679 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035341201
150 rdf:type schema:CreativeWork
151 https://doi.org/10.1056/nejmoa1607017 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084964859
152 rdf:type schema:CreativeWork
153 https://doi.org/10.1056/nejmoa1615975 schema:sameAs https://app.dimensions.ai/details/publication/pub.1092274251
154 rdf:type schema:CreativeWork
155 https://doi.org/10.1056/nejmoa1615977 schema:sameAs https://app.dimensions.ai/details/publication/pub.1092274246
156 rdf:type schema:CreativeWork
157 https://doi.org/10.1056/nejmra1505557 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084149679
158 rdf:type schema:CreativeWork
159 https://doi.org/10.1080/14712598.2016.1198765 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029187928
160 rdf:type schema:CreativeWork
161 https://doi.org/10.1111/bjd.15152 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018287212
162 rdf:type schema:CreativeWork
163 https://doi.org/10.1111/bjd.15857 schema:sameAs https://app.dimensions.ai/details/publication/pub.1090920617
164 rdf:type schema:CreativeWork
165 https://doi.org/10.1136/annrheumdis-2012-203091 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038077135
166 rdf:type schema:CreativeWork
167 https://doi.org/10.1136/annrheumdis-2013-203696 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029726499
168 rdf:type schema:CreativeWork
169 https://doi.org/10.1136/annrheumdis-2013-204655 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041188784
170 rdf:type schema:CreativeWork
171 https://doi.org/10.1136/annrheumdis-2013-204902 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002806444
172 rdf:type schema:CreativeWork
173 https://doi.org/10.1136/annrheumdis-2013-205056 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004467907
174 rdf:type schema:CreativeWork
175 https://doi.org/10.1136/annrheumdis-2015-207963 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002021761
176 rdf:type schema:CreativeWork
177 https://doi.org/10.1136/annrheumdis-2015-208337 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022767391
178 rdf:type schema:CreativeWork
179 https://doi.org/10.1136/annrheumdis-2016-209709 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044839867
180 rdf:type schema:CreativeWork
181 https://doi.org/10.1136/annrheumdis-2016-210105 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062759478
182 rdf:type schema:CreativeWork
183 https://doi.org/10.1136/annrheumdis-2016-210724 schema:sameAs https://app.dimensions.ai/details/publication/pub.1085328641
184 rdf:type schema:CreativeWork
185 https://doi.org/10.1136/annrheumdis-2017-212127 schema:sameAs https://app.dimensions.ai/details/publication/pub.1099928962
186 rdf:type schema:CreativeWork
187 https://doi.org/10.1136/annrheumdis-2017-eular.1164 schema:sameAs https://app.dimensions.ai/details/publication/pub.1095977238
188 rdf:type schema:CreativeWork
189 https://doi.org/10.1517/14712598.2015.1103733 schema:sameAs https://app.dimensions.ai/details/publication/pub.1067589152
190 rdf:type schema:CreativeWork
191 https://doi.org/10.3899/jrheum.151376 schema:sameAs https://app.dimensions.ai/details/publication/pub.1071544067
192 rdf:type schema:CreativeWork
193 https://www.grid.ac/institutes/grid.17063.33 schema:alternateName University of Toronto
194 schema:name Centre for Prognosis Studies in the Rheumatic Diseases, Krembil Research Institute, Toronto Western Hospital, University Health Network Toronto, 1E 416, 399 Bathurst Street, M5T 2S8, Toronto, ON, Canada
195 Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada
196 Department of Medicine, Division of Rheumatology, University of Toronto, Toronto, Canada
197 Department of Medicine, Division of Rheumatology, University of Toronto, Toronto, ON, Canada
198 Institute of Medical Science, University of Toronto, Toronto, ON, Canada
199 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...